Susan Smith Laura's Insider Trades & SAST Disclosures

Susan Smith Laura's most recent trade in Y-Mabs Therapeutics Inc was a trade of 1,682 Common Stock done at an average price of $16.5 . Disclosure was reported to the exchange on March 5, 2024.

Share

Note

This is a custom search result for pattern Susan Smith Laura.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Y-Mabs Therapeutics Inc	Susan Laura Smith	SVP & CHIEF COMMERCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 16.55 per share.	05 Mar 2024	1,682	33,918 (0%)	0%	16.5	27,837	Common Stock
Y-Mabs Therapeutics Inc	Susan Laura Smith	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2024	35,700	35,700	-		-	Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc	Susan Smith Laura	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2024	17,800	35,600 (0%)	0%		0	Common Stock
Y-Mabs Therapeutics Inc	Susan Laura Smith	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	32,000	32,000	-		-	Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc	Susan Laura Smith	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2023	35,700	35,700	-		-	Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc	Susan Laura Smith	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2023	17,800	17,800 (0%)	0%		0	Common Stock
Y-Mabs Therapeutics Inc	Susan Laura Smith	SVP & CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Apr 2022	20,000	20,000	-		-	Employee Stock Option (right to buy)
Y-Mabs Therapeutics Inc	Susan Laura Smith	SVP & CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Dec 2021	64,000	64,000	-		-	Employee Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades